Shire Pharmaceuticals Limited
- A06 - Agentes contra el estreñimiento
- RESOLOR film-coated tablet 1 mg
- RESOLOR film-coated tablet 2 mg
- A07 - Antidiarreicos, antiinfecciosos y antiinflamatorios intestinales
- MEZAVANT XL prolonged-release tablet 1 200 mg
- A16 - Otros productos para el tracto alimentario y metabolismo
- REVESTIVE powder and solvent for solution for injection 1.25 mg
- REVESTIVE powder and solvent for solution for injection 5 mg
- B06 - Otros agentes hematológicos
- FIRAZYR solution for injection 30 mg/10 ml
- C02 - Antihipertensivos
- INTUNIV prolonged-release tablet 1 mg
- INTUNIV prolonged-release tablet 2 mg
- INTUNIV prolonged-release tablet 3 mg
- INTUNIV prolonged-release tablet 4 mg
- H05 - Homeostasis del calcio
- NATPAR powder and solvent for solution for injection 100 µg/dose
- NATPAR powder and solvent for solution for injection 25 µg/dose
- NATPAR powder and solvent for solution for injection 50 µg/dose
- NATPAR powder and solvent for solution for injection 75 µg/dose
- N06 - Psicoanalépticos
- EQUASYM XL modified-release capsule, hard 10 mg
- EQUASYM XL modified-release capsule, hard 20 mg
- EQUASYM XL modified-release capsule, hard 30 mg
- EQUASYM XL modified-release capsule, hard 40 mg
- EQUASYM XL modified-release capsule, hard 50 mg
- EQUASYM XL modified-release capsule, hard 60 mg
- REMINYL oral solution 4 mg/ml
- REMINYL prolonged-release capsule, hard 16 mg
- REMINYL prolonged-release capsule, hard 24 mg
- REMINYL prolonged-release capsule, hard 8 mg
- V03 - Todos los demás preparados terapéuticos
- FOZNOL chewable tablet 1 000 mg
- FOZNOL chewable tablet 250 mg
- FOZNOL chewable tablet 500 mg
- FOZNOL chewable tablet 750 mg
- FOZNOL oral powder 1 000 mg
- FOZNOL oral powder 750 mg